Buscar
Mostrando ítems 21-30 de 73
Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial
(ROYAL COLLEGE OF PSYCHIATRISTS, 2011)
Background Two recent clinical studies support the feasibility of trials to evaluate the disease-modifying properties of lithium in Alzheimer`s disease, although no benefits were obtained from short-term treatment. Aims ...
Promotion Effect Of Platinum On Golds Reactivity: A High-resolution Photoelectron Spectroscopy Study
(American Chemical Society, 2016)
Deposition of Hyperphosphorylated Tau in Cerebellum of PS1 E280A Alzheimer’s Disease
(International Society of NeuropathologyGrupo de Neurociencias de AntioquiaZúrich, Suiza, 2022)
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
(Nature Publishing Group, 2020-03)
Development of tau-based therapies for Alzheimer’s disease requires an understanding of the timing of disease-related changes in tau. We quantified the phosphorylation state at multiple sites of the tau protein in cerebrospinal ...
Aumento dos níveis de csf de tau total em pacientes com patologia subcutânea cerebrovascular e comprometimento cognitivo
(2017-10-01)
Cognitive impairment includes mild cognitive decline and dementia, such as Alzheimer’s disease (AD) and cerebrovascular-related pathologies. Objective: To investigate the profile of AD-related CSF biomarkers in a sample ...
Electronic And Structural Study Of Pt-modified Au Vicinal Surfaces: A Model System For Pt-au Catalysts
(Royal Society of Chemistry, 2014)
Promotion Effect Of Platinum On Golds Reactivity: A High-resolution Photoelectron Spectroscopy Study
(American Chemical Society, 2016)
Promotion Effect Of Platinum On Gold's Reactivity: A High-resolution Photoelectron Spectroscopy Study
(Amer Chemical SocWashington, 2016)